Analysis of bulk drug lot NSC 777586
Ended Awarded Last action
- Contract number
- 75N91019F00129
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,873
Award facts
- Contract value 100% obligated
- $24,872.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$13 | |
| Original award | $24,886 |
Quick answers
Who was awarded contract 75N91019F00129?
75N91019F00129 was awarded to Sri International by National Cancer Institute (National Institutes of Health) on September 22, 2019.
How much is contract 75N91019F00129 worth?
The government has obligated $24,873 on 75N91019F00129.
Is contract 75N91019F00129 an order under another contract?
Yes. 75N91019F00129 is a delivery order under HHSN261201700014I, an indefinite delivery contract, on NIH Analysis of Anti-Cancer Chemicals 2017-2022.
Was contract 75N91019F00129 competed?
The extent of competition for 75N91019F00129 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award